TY - JOUR T1 - Effect of Empagliflozin on Left Ventricular Volumes in Patients with Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF) JO - Circulation PY - 2020/11/13 AU - Lee MMY AU - Brooksbank KJM AU - Wetherall K AU - Mangion K AU - Roditi G AU - Campbell RT AU - Berry C AU - Chong V AU - Coyle L AU - Docherty KF AU - Dreisbach JG et al ED - DO - DOI: 10.1161/circulationaha.120.052186 PB - Ovid Technologies (Wolters Kluwer Health) Y2 - 2025/07/17 ER -